DUPUYTREN LITERATURE: ELASTIN

These materials are available for nonprofit educational use. This repository is allowed by copyright disclaimer under title 17, Appendix E, section 107 of the United States Copyright Act. Under this statute, allowance is made for “fair use” for purposes such as criticism, comment, news reporting, teaching, scholarship, and research. As defined, fair use specifically applies to this repository.

Medline Title Search (Dupuytren + Elastin)

Selected Publications

• Almine, J. F., Wise, S. G., Hiob, M., Singh, N. K., Tiwari, K. K., Vali, S., … Weiss, A. S. (2013). Elastin sequences trigger transient proinflammatory responses by human dermal fibroblasts. FASEB Journal, 27(9), 3455–3465. (PDF)
• Barroso, B., Abello, N., & Bischoff, R. (2006). Study of human lung elastin degradation by different elastases using high-performance liquid chromatography/mass spectrometry. Analytical Biochemistry, 358(2), 216–224. (PDF)
• Baydanoff, S., Nicoloff, G., & Alexiev, C. (1987). Age-related changes in anti-elastin antibodies in serum from normal and atherosclerotic subjects. Atherosclerosis, 63(2–3), 267–271. (PDF)
• Brouwer, B. De, Drent, M., Ouweland, J. M. W. Van Den, Wijnen, P. A., Moorsel, C. H. M. Van, Bekers, O., … Janssen, R. (2018). Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis, 1–4. (PDF)
• Durand, E., Fournier, B., Couty, L., Lemitre, M., Achouh, P., Julia, P., … Lafont, A. (2012). Endoluminal gingival fibroblast transfer reduces the size of rabbit carotid aneurisms via elastin repair. Arteriosclerosis, Thrombosis, and Vascular Biology, 32(8), 1892–1901. (PDF)
• Hansen, N. U. B., Karsdal, M. A., Brockbank, S., Cruwys, S., Rønnow, S., & Leeming, D. J. (2016). Tissue turnover of collagen type I, III and elastin is elevated in the PCLS model of IPF and can be restored back to vehicle levels using a phosphodiesterase inhibitor. Respiratory Research, 17(1), 1–10. (PDF)
• Hirsch, E., & Ghigo, A. (2014). Elastin degradation and ensuing inflammation as emerging keys to atherosclerosis. Cardiovascular Research, 102(1), 1–2. (PDF)
• Hong YJ, Kim J, et al (2012). Serum elastin-derived peptides and anti-elastin antibody in patients with systemic sclerosis. Journal of Korean Medical Science, 27(5), 484–488. (PDF)
• Ingram, J. L., Slade, D., Church, T. D., Francisco, D., Heck, K., Wesley Sigmon, R., … Kraft, M. (2016). Role of matrix metalloproteinases-1 and-2 in interleukin-13-suppressed elastin in airway fibroblasts in asthma. American Journal of Respiratory Cell and Molecular Biology, 54(1), 41–50. (PDF)
• Lee, S. M., Chiang, S. H., Wang, H. Y., Wu, P. S., & Lin, C. C. (2015). Curcumin enhances the production of major structural components of elastic fibers, elastin, and fibrillin-1, in normal human fibroblast cells. Bioscience, Biotechnology and Biochemistry, 79(2), 247–252. (PDF)
• Luisetti, M., Ma, S., Iadarola, P., Stone, P. J., Viglio, S., Casado, B., … Turino, G. M. (2008). Desmosine as a biomarker of elastin degradation in COPD: Current status and future directions. European Respiratory Journal, 32(5), 1146–1157. (PDF)
• Ma, S., Turino, G. M., & Lin, Y. Y. (2011). Quantitation of desmosine and isodesmosine in urine, plasma, and sputum by LC-MS/MS as biomarkers for elastin degradation. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 879(21), 1893–1898. (PDF)
• Ma, S., Lin, Y. Y., Cantor, J. O., Chapman, K. R., Sandhaus, R. A., Fries, M., … Turino, G. M. (2017). The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency : An Analysis of the RAPID / RAPID Extension Trials. Journal of the COPD Foundation, 4(1), 34–44. (PDF)
• Melling, M., Karimian-Teherani, D., Mostler, S., Behnam, M., Sobal, G., & Menzel, E. J. (2000). Changes of biochemical and biomechanical properties in Dupuytren disease. Arch Pathol Lab Med, 124(9), 1275–1281. (PDF)
• Menzel, E. J., Neumuller, J., Rietsch, A., & Millesi, H. (1994). Connective Tissue Autoantibodies in Dupuytren’s Disease: Associations with HLA DR3. In Dupuytren’s Disease Pathobiochemistry and Clinical Management (pp. 49–61). (PDF)
• Millesi, H. (1974). The Clinical And Morphological Course Of Dupuytren’s Disease. In J. Hueston & R. Tubiana (Eds.), Dupuytren’s Disease (pp. 49–60). Grune& Stratton, London. (PDF)
• Millesi, H., Reihserner, R., Menzel, J., Hamilton, G., & Mallinger, R. (1994). Changes in the Biochemical Properties of Diseased Tissue as Pathogenetic Factors in Dupuytren’s Contracture. In Dupuytren’s Disease Pathobiochemistry and Clinical Management (pp. 178–189). Springer-Verlag. (PDF)
• Millesi, H., Reihsner, R., Hamilton, G., Mallinger, R., & Menzel, E. J. (1995). Biomechanical properties of normal tendons, normal palmar aponeuroses, and tissues from patients with Dupuytren’s disease subjected to elastase and chondroitinase treatment. Clin Biomech (Bristol, Avon), 10(1), 29–35. (PDF)
• Millesi, H., Reihsner, R., Hamilton, G., Mallinger, R., & Menzel, E. J. (1995). Biomechanical properties of normal tendons, normal palmar aponeuroses and palmar aponeuroses from patients with Dupuytren’s disease subjected to elastase and chondroitinase treatment. Connect Tissue Res, 31(2), 109–115. (PDF)
• Millesi, H., Reihsner, R., Eberhard, D., Mallinger, R., Hamilton, G., & Menzel, E. J. (1997). The mechanical properties of the palmar aponeurosis and their significance for the pathogenesis of dupuytren’s contracture. Journal of Hand Surgery: European Volume, 22(4), 510–517. https://doi.org/10.1016/S0266-7681(97)80279-3 (PDF)
• Millesi, H. (2012). Basic Thoughts on Dupuytren’s Contracture. In C. E. et al. (eds.) (Ed.), Dupuytren’s Disease and Related Hyperproliferative Disorders (pp. 21–26). Springer-Verlag Berlin Heidelberg. https://doi.org/10.1007/978-3-642-22697-7 (PDF)
• Neumüller, J., Menzel, J., & Millesi, H. (1994). Prevalence of HLA-DR3 and autoantibodies to connective tissue components in Dupuytren’s contracture. Clinical Immunology and Immunopathology, 71(2), 142–148. https://doi.org/10.1006/clin.1994.1064 (PDF)
• Robert, L., & Labat-Robert, J. (2014). Circulating elastin peptides, role in vascular pathology. Pathologie Biologie, 62(6), 337–341. (PDF)
• Shemesh, S., Sidon, E., Kaisler, E., Sheinis, D., Velkes, S., Ohana, N., & Benayahu, D. (2017). Diabetes mellitus is associated with increased elastin fiber loss in ligamentum flavum of patients with lumbar spinal canal stenosis: results of a pilot histological study. European Spine Journal, 1–9. (PDF)
• Skjøt-Arkil, H., Clausen, R. E., Nguyen, Q. H. T., Wang, Y., Zheng, Q., Martinez, F. J., … Karsdal, M. A. (2012). Measurement of MMP-9 and -12 degraded elastin (ELM) provides unique information on lung tissue degradation. BMC Pulmonary Medicine, 12. (PDF)
• Smith, E. R., Tomlinson, L. A., Ford, M. L., McMahon, L. P., Rajkumar, C., & Holt, S. G. (2012). Elastin degradation is associated with progressive aortic stiffening and all-cause mortality in predialysis chronic kidney disease. Hypertension, 59(5), 973–978. (PDF)
• Stein, F., Pezess, M. P., Robert, L., & Poullain, N. (1965). Anti-elastin antibodies in normal and pathological human sera. Nature, 207(994), 312–313. (PDF)
• Stewart, S., Malto, M., Sandberg, L., & Colburn, K. K. (1994). Increased serum levels of anti-elastin antibodies in patients with Peyronie’s disease. J Urol, 152(1), 105–106. (PDF)
• Stone, P. J., Korn, J. H., North, H., Lally, E. V, Miller, L. C., Tucker, L. B., … Franzblau, C. (1995). Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma. Arthritis and Rheumatism, 38(4), 517–524. (PDF)
• Turino, G. M., Lin, Y. Y., He, J., Cantor, J. O., & Ma, S. (2012). Elastin degradation: An effective biomarker in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease, 9(4), 435–438. (PDF)
• Tyrkkö J and Viljanto J (1975) Significance of histopathological findings in Dupuytren’s contracture. Annales chirurgiae et gynaecologiae Fenniae 64(5). 1975/01/01.: 288–291. (PDF)
• Tzvetanov, P., Hegde, V., Al-Hashel, J. Y., Atanasova, M., Sohal, A. P. S., & Rousseff, R. T. (2014). Abnormal levels of serum anti-elastin antibodies in patients with symptomatic carotid stenosis. Clinical Neurology and Neurosurgery, 116, 9–12. (PDF)
• Viglio, S., Annovazzi, L., Luisetti, M., Stolk, J., Casado, B., & Iadarola, P. (2007). Progress in the methodological strategies for the detection in real samples of desmosine and isodesmosine, two biological markers of elastin degradation. Journal of Separation Science, 30(2), 202–213. (PDF)
• Zhang, J., Wu, L., Feng, M. xiang, Sexton, P., Bai, C. xue, Qu, J. ming, … Black, P. N. (2011). Pulmonary fibroblasts from COPD patients show an impaired response of elastin synthesis to TGF-ß1. Respiratory Physiology and Neurobiology, 177(3), 236–240. (PDF)